Hare Joshua — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Hare Joshua has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Profile

Joshua Hare is the Chief Scientific Officer at Longeveron Inc., a clinical-stage biotechnology company focused on developing regenerative medicines. He has contributed to the company's efforts in addressing aging-related and life-threatening conditions through innovative stem cell therapies.

Board memberships

• Longeveron Inc.

Awards & honors

• Leadership in regenerative medicine research
• Development of Lomecel-B
• Contributions to clinical trials for aging-related conditions

Recent Transactions

Companies — Last 90 Days

• Longeveron Inc. (LGVN) — 1 filings, last 2026-07-08

Frequently Asked Questions

Who is Hare Joshua?

Joshua Hare is the Chief Scientific Officer at Longeveron Inc., a clinical-stage biotechnology company focused on developing regenerative medicines. He has contributed to the company's efforts in addressing aging-related and life-threatening conditions through innovative stem cell therapies.…

How many SEC Form 4 filings has Hare Joshua submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Where can I see all of Hare Joshua's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week